Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
EBBELING ROBERT B
  2. Issuer Name and Ticker or Trading Symbol
HAEMONETICS CORP [HAE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Vice President, Operations
(Last)
(First)
(Middle)
400 WOOD ROAD
3. Date of Earliest Transaction (Month/Day/Year)
02/13/2007
(Street)

BRAINTREE, MA 02184
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/13/2007   M   2,300 A $ 17 26,160 D  
Common Stock 02/13/2007   S   2,300 D $ 47.0252 23,860 D  
Common Stock 02/13/2007   M   10,000 A $ 17 33,860 D  
Common Stock 02/13/2007   S   10,000 D $ 47.014 23,860 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $ 17 02/13/2007   M     2,300 02/13/2007(1) 04/18/2007 Common Stock 2,300 $ 47.0161 10,000 D  
Non-Qualified Stock Option (right to buy) $ 17 02/13/2007   M     10,000 02/13/2007(2) 04/18/2007 Common Stock 10,000 $ 47.0161 0 D  
Non-Qualified Stock Option (right to buy) $ 15.4063               (1) 04/01/2009 Common Stock 10,500   10,500 D  
Non-Qualified Stock Option (right to buy) $ 15.875               (3) 05/03/2009 Common Stock 18,904   18,904 D  
Non-Qualified Stock Option (right to buy) $ 22.9063               (4) 05/01/2010 Common Stock 19,927   19,927 D  
Non-Qualified Stock Option (right to buy) $ 26.105               (1) 05/05/2014 Common Stock 15,000   15,000 D  
Non-Qualified Stock Option (right to buy) $ 31.66               (1) 04/29/2012 Common Stock 22,000   22,000 D  
Non-Qualified Stock Option (right to buy) $ 33.15               (1) 04/30/2011 Common Stock 10,000   10,000 D  
Non-Qualified Stock Option (right to buy) $ 41.15               (1) 07/27/2012 Common Stock 19,000   19,000 D  
Non-Qualified Stock Option (right to buy) $ 52.76             05/05/2007(1) 05/05/2013 Common Stock 16,644   16,644 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
EBBELING ROBERT B
400 WOOD ROAD
BRAINTREE, MA 02184
      Vice President, Operations  

Signatures

 By: Susan Hanlon For: Robert B Ebbeling   02/15/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
(2) Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the fifth anniversary of the date of grant. Vesting is accelerated when the fair market value of Haemonetics share price exceeds certain target levels for ten consecutive days.
(3) Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 50 percent beginning on the first anniversary of the date of grant.
(4) Grant to reporting person of right to buy shares of common stock, exercisable 50% on 3/31/2001 and 50% on 3/31/2002.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.